Circulating MicroRNAs in Plasma of Hepatitis B e Antigen Positive Children Reveal Liver-Specific Target Genes
暂无分享,去创建一个
F. Pociot | B. Høgh | T. N. Winther | K. Jacobsen | A. Mirza | I. Heiberg | C. Bang-Berthelsen | Aashiq H. Mirza | B. Hogh | Kari Jacobsen
[1] A. Patel,et al. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[2] C. J. Chen,et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. , 2000, Journal of the National Cancer Institute.
[3] S. Thorgeirsson,et al. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis , 2000, Oncogene.
[4] K. Furuyama,et al. Expression of coproporphyrinogen oxidase and synthesis of hemoglobin in human erythroleukemia K562 cells. , 2001, European journal of biochemistry.
[5] M. Katoh,et al. Molecular cloning and characterization of FRAT2, encoding a positive regulator of the WNT signaling pathway. , 2001, Biochemical and biophysical research communications.
[6] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[7] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[8] B. McMahon,et al. Chronic hepatitis B: Update of recommendations , 2004, Hepatology.
[9] H. Will,et al. The hepatitis B virus PRE contains a splicing regulatory element , 2006, Nucleic acids research.
[10] S. Thorgeirsson,et al. Oncogene‐specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis , 2006, Hepatology.
[11] E. Moran,et al. The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest. , 2006, Cancer research.
[12] A. Gatta,et al. Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29‐year longitudinal study , 2006, Hepatology.
[13] Jiang Qian,et al. TiGER: A database for tissue-specific gene expression and regulation , 2008, BMC Bioinformatics.
[14] A. Giannattasio,et al. Long-term outcome in children with chronic hepatitis B: a 24-year observation period. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] S. Shieh,et al. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1 , 2007, The EMBO journal.
[16] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[17] H. Hsu,et al. Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion. , 2007, Gastroenterology.
[18] F. Haller,et al. Altered regulation of Prox1-gene-expression in liver tumors , 2008, BMC Cancer.
[19] Joan M. Block,et al. Recommendations for Screening, Monitoring, and Referral of Pediatric Chronic Hepatitis B , 2009, Pediatrics.
[20] Yi Tie,et al. MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. , 2010, European journal of cancer.
[21] Wenlin Huang,et al. Cellular MicroRNAs Inhibit Replication of the H1N1 Influenza A Virus in Infected Cells , 2010, Journal of Virology.
[22] N. Kiviat,et al. DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection. , 2010, Experimental and molecular pathology.
[23] Chi Zhang,et al. TiSGeD: a database for tissue-specific genes , 2010, Bioinform..
[24] Ryan M. O’Connell,et al. Physiological and pathological roles for microRNAs in the immune system , 2010, Nature Reviews Immunology.
[25] Y. Doki,et al. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. , 2010, Journal of hepatology.
[26] Hui Zhou,et al. starBase: a database for exploring microRNA–mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data , 2010, Nucleic Acids Res..
[27] Peng-jun Zhang,et al. Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies , 2010, Clinical science.
[28] Paul J Rider,et al. A liver‐specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] M. Zavolan,et al. Analysis of in situ pre-mRNA targets of human splicing factor SF1 reveals a function in alternative splicing , 2010, Nucleic acids research.
[30] T. Ishikawa,et al. Enhanced expression of coproporphyrinogen oxidase in malignant brain tumors: CPOX expression and 5-ALA-induced fluorescence. , 2011, Neuro-oncology.
[31] Q. Ye,et al. Identification of Suitable Reference Genes for qRT-PCR Analysis of Circulating microRNAs in Hepatitis B Virus-Infected Patients , 2011, Molecular Biotechnology.
[32] M. Esteller. Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.
[33] R. Yang,et al. Let-7c MicroRNA Expression and Clinical Significance in Hepatocellular Carcinoma , 2011, The Journal of international medical research.
[34] EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. , 2012, Journal of hepatology.
[35] Tao Huang,et al. Differential combinatorial regulatory network analysis related to venous metastasis of hepatocellular carcinoma , 2012, BMC Genomics.
[36] Keith A. Boroevich,et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators , 2012, Nature Genetics.
[37] Lanjuan Li,et al. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. , 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[38] Boping Zhou,et al. Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma , 2012, Nature Genetics.
[39] S. Dalton,et al. Frat Is a Phosphatidylinositol 3-Kinase/Akt-Regulated Determinant of Glycogen Synthase Kinase 3β Subcellular Localization in Pluripotent Cells , 2012, Molecular and Cellular Biology.
[40] X. Gu,et al. microRNA expression profiles in human colorectal cancers with brain metastases. , 2012, Oncology letters.
[41] Sukriti,et al. Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection , 2012, Clinical and Translational Gastroenterology.
[42] Haoliang Zhao,et al. MicroRNA-125b Functions as a Tumor Suppressor in Hepatocellular Carcinoma Cells , 2012, International journal of molecular sciences.
[43] S. Imbeaud,et al. Next-generation sequencing identified new oncogenes and tumor suppressor genes in human hepatic tumors , 2012, Oncoimmunology.
[44] Y. Mao,et al. Serum miR-18a: A Potential Marker for Hepatitis B Virus-Related Hepatocellular Carcinoma Screening , 2012, Digestive Diseases and Sciences.
[45] L. Yao,et al. Smad4 expression in hepatocellular carcinoma differs by hepatitis status. , 2012, Asian Pacific journal of cancer prevention : APJCP.
[46] F. Pociot,et al. Differential Plasma MicroRNA Profiles in HBeAg Positive and HBeAg Negative Children with Chronic Hepatitis B , 2013, PloS one.
[47] G. Yousef,et al. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. , 2013, Lung cancer.
[48] G. Mieli-Vergani,et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition. , 2013, Journal of hepatology.
[49] F. Pociot,et al. Hepatitis B Surface Antigen Quantity Positively Correlates with Plasma Levels of microRNAs Differentially Expressed in Immunological Phases of Chronic Hepatitis B in Children , 2013, PloS one.
[50] S. Kauppinen,et al. Treatment of HCV infection by targeting microRNA. , 2013, The New England journal of medicine.
[51] P. Ye,et al. MicroRNAs may solve the mystery of chronic hepatitis B virus infection. , 2013, World journal of gastroenterology.
[52] Je-Yoel Cho,et al. MicroRNA-365 regulates NKX2-1, a key mediator of lung cancer. , 2013, Cancer letters.
[53] F. Shen,et al. GATA6 predicts prognosis and hepatic metastasis of colorectal cancer. , 2013, Oncology reports.
[54] C. Larsson,et al. MicroRNA Expression Patterns Related to Merkel Cell Polyomavirus Infection in Human Merkel Cell Carcinoma , 2013, The Journal of investigative dermatology.
[55] A. Levine,et al. MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells , 2014, Oncogene.